[August 11, 2016]

Global DNA Sequencing Market to Grow 19.30% by 2022 - Driven by Increasing Use of Personalized Medicines - Research and Markets

Research and Markets has announced the addition of the "Global DNA Sequencing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022" report to their offering.

The major factor which is contributing towards the growth of the market is the rising research and development spending by biotechnology companies. The major key players are investing huge amount of money on the research and development activities. Region wise, Europe's research spending was the high in 2013, with UK spending $1.2 billion on R&D; France spending $695 million; and, Germany putting up $147 million in the same year. Also, the increasing demand for personalized medicine is anticipated to fuel the growth of global market.

The increasing use of personalized medicines is increasing the scope of DNA sequencing technology in the global market. By the use of personalized medicines, the 5-year survival rate is increased to 70%. Personalized medicines help to reduce the cost of healthcare hat is the primary reason for its increasing demand, worldwide. In 2015, it is estimated that around $604 million healthcare cost is saved by the use of personalized medicines.

There are many factors that are driving growth in the market; however, there are also some challenges, such as dearth of effective bioinformatics tools which helps the researcher to innovate new technology is the major challenge that can be surpassed during the forecast period. The absence of skilled professionals and requirement of high capital investment are the major restraints which are hindering the growth of global DNA sequencing technology market.

Companies Mentioned:

• 23Andme, Inc.
• Adaptive Biotechnologies, Inc.
• Agilent (News - Alert) Technologies, Inc.
• Appistry, Inc.
• Asuragen, Inc.
• Athena Diagnostics, Inc.
• Cell Microsystems,, Inc.
• Cellular Research, Inc.
• Spiral Genetics, Inc.
• Sundance Diagnostics, Inc.
• Sure Genomics, Inc.
• Thermo Fisher Scientific, Inc.
• Thorne Diagnostics, Inc.
• Ubiquity Genomics, Inc.
• Wafergen Bio-Systems, Inc.
  

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Sector Analysis

5. Market Segmentation

6. Competitive Landscape

7. Geographical Analysis

8. Company Profiles

For more information visit http://www.researchandmarkets.com/research/9zqqtx/global_dna

View source version on businesswire.com: http://www.businesswire.com/news/home/20160811005523/en/

[ Back To TMCnet.com's Homepage ]